Rexahn Pharma (RNN) Tops Q1 EPS by 1c

Rexahn Pharma (NYSE: RNN) reported Q1 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03).

For earnings history and earnings-related data on Rexahn Pharma (RNN) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
• Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18